Assessment of Tumoricidal Efficacy and Response to Treatment with18F-FDG PET/CT After Intraarterial Infusion with the Antiglycolytic Agent 3-Bromopyruvate in the VX2 Model of Liver Tumor
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.